FDA Determines Regulatory Review Period for ASPIRE ASSIST Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially approved the regulatory review period for ASPIRE ASSIST, a medical device patent extension application submitted to the US Patent and Trademark Office (USPTO).